Recent publications
Article
Alenazy, F, Harbi, M, Kavanagh, D, Price, J, Brady, P, Hargreaves, O, Harrison, P, Slater, A, Tiwari, A, Nicolson, P, Connolly, D, Kirchhof, P, Kalia, N, Jandrot-Perrus, M, Mangin, PH, Watson, S & Thomas, MR 2023, 'Amplified inhibition of atherosclerotic plaque-induced platelet activation by glenzocimab with dual antiplatelet therapy JTH', Journal of thrombosis and haemostasis : JTH, vol. 21, no. 11, pp. 3236-3251. https://doi.org/10.1016/j.jtha.2023.07.018
Schönichen, C, Montague, SJ, Brouns, SLN, Burston, JJ, Cosemans, JMEM, Jurk, K, Kehrel, BE, Koenen, RR, Ní Áinle, F, O'Donnell, VB, Soehnlein, O, Watson, SP, Kuijpers, MJE, Heemskerk, JWM & Nagy, M 2023, 'Antagonistic Roles of Human Platelet Integrin αIIbβ3 and Chemokines in Regulating Neutrophil Activation and Fate on Arterial Thrombi Under Flow', Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/ATVBAHA.122.318767
Damaskinaki, F-N, Jooss, NJ, Martin, EM, Clark, JC, Thomas, MR, Poulter, NS, Emsley, J, Kellam, B, Watson, SP & Slater, A 2023, 'Characterizing the binding of glycoprotein VI with nanobody 35 reveals a novel monomeric structure of glycoprotein VI where the conformation of D1+D2 is independent of dimerization', Journal of thrombosis and haemostasis : JTH, vol. 21, no. 2, pp. 317-328. https://doi.org/10.1016/j.jtha.2022.11.002
Clark, JC, Martin, EM, Morán, LA, Di, Y, Wang, X, Zuidscherwoude, M, Brown, HC, Kavanagh, DM, Hummert, J, Eble, JA, Nieswandt, B, Stegner, D, Pollitt, AY, Herten, D, Tomlinson, MG, García, A & Watson, SP 2023, 'Divalent nanobodies to platelet CLEC-2 can serve as agonists or antagonists', Communications Biology, vol. 6, no. 1, 376. https://doi.org/10.1038/s42003-023-04766-6
Gauer, J, Duval, C, Xu, R-G, Macrae, FL, McPherson, H, Tiede, C, Tomlinson, D, Watson, S & Ariëns, RAS 2023, 'Fibrin-glycoprotein VI interaction increases platelet procoagulant activity and impacts clot structure', Journal of Thrombosis and Haemostasis, vol. 21, no. 3, pp. 667-681. https://doi.org/10.1016/j.jtha.2022.09.004
Kardeby, C, Evans, A, Campos, J, Al-Wahaibi, AM, Smith, C, Slater, A, Martin, E, Severin, S, Brill, A, Pejler, G, Sun, Y & Watson, S 2023, 'Heparin and heparin proteoglycan-mimetics activate platelets via PEAR1 and PI3Kβ', Journal of Thrombosis and Haemostasis, vol. 21, no. 1, pp. 101-116. https://doi.org/10.1016/j.jtha.2022.10.008
Buka, R, Montague, S, Moran, LA, Martin, E, Slater, A, Watson, S & Nicolson, P 2023, 'PF4 activates the c-Mpl-Jak2 pathway in platelets', Blood. https://doi.org/10.1182/blood.2023020872
Jooss, NJ, Smith, CW, Pike, JA, Farndale, RW, Henskens, YMC, Watson, SP, Heemskerk, JWM & Poulter, NS 2023, 'Platelet glycoprotein VI cluster size is related to thrombus formation and phosphatidylserine exposure in collagen-adherent platelets under arterial shear', Journal of thrombosis and haemostasis : JTH, vol. 21, no. 8, pp. 2260-2267. https://doi.org/10.1016/j.jtha.2023.04.028
Martin, E, Clark, J, Montague, S, Moran, LA, Di, Y, Bull, LJ, Whittle, L, Raka, F, Buka, R, Zafar, I, Kardeby, C, Slater, A & Watson, S 2023, 'Trivalent nanobody-based ligands mediate powerful activation of GPVI, CLEC-2 and PEAR1 in human platelets whereas FcγRIIA requires a tetravalent ligand', Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2023.09.026
Clark, J, Watson, S & Owen, D 2023, 'Validation of agent-based models of surface receptor oligomerisation', Trends in Pharmacological Sciences, vol. 44, no. 10, pp. 643-646. https://doi.org/10.1016/j.tips.2023.07.002
Kemble, S, Dalby, A, Lowe, G, Nicolson, P, Watson, S, Senis, Y, Thomas, S & Harrison, P 2022, 'Analysis of preplatelets and their barbell platelet derivatives by imaging flow cytometry', Blood Advances, vol. 6, no. 9, pp. 2932–2946. https://doi.org/10.1182/bloodadvances.2021006073
Jooss, NJ, Smith, CW, Slater, A, Montague, SJ, Di, Y, O'shea, C, Thomas, MR, Henskens, YMC, Heemskerk, JWM, Watson, SP & Poulter, NS 2022, 'Anti-GPVI nanobody blocks collagen- and atherosclerotic plaque-induced GPVI clustering, signaling and thrombus formation', Journal of Thrombosis and Haemostasis, vol. 20, no. 11, pp. 2617-2631. https://doi.org/10.1111/jth.15836
Montague, S, Smith, C, Lodwick, CS, Stoneley, C, Roberts, M, Lowe, G, Lester, W, Watson, S & Nicolson, P 2022, 'Anti-platelet factor 4 immunoglobulin G levels in vaccine-induced immune thrombocytopenia and thrombosis: persistent positivity through 7 months', Research and Practice in Thrombosis and Haemostasis, vol. 6, no. 3, e12707. https://doi.org/10.1002/rth2.12707
Harbi, M, Smith, C, Alenazy, F, Nicolson, P, Tiwari, A, Watson, S & Thomas, MR 2022, 'Antithrombotic effects of fostamatinib in combination with conventional antiplatelet drugs', International Journal of Molecular Sciences, vol. 23, no. 13, 6982. https://doi.org/10.3390/ijms23136982
Letter
Brown, HC, Beck, S, Navarro, S, Di, Y, Soriano jerez, EM, Kaczmarzyk, J, Thomas, SG, Mirakaj, V, Watson, SP, Nieswandt, B & Stegner, D 2023, 'Antibody-mediated depletion of human CLEC-2 in a novel humanized mouse model', Blood Advances, vol. 7, no. 6, pp. 997–1000. https://doi.org/10.1182/bloodadvances.2021006463
View all publications in research portal